US Stock MarketDetailed Quotes

BIIB Biogen

Watchlist
  • 228.330
  • +3.310+1.47%
Close Jul 17 16:00 ET
  • 228.330
  • 0.0000.00%
Post 18:55 ET
33.24BMarket Cap28.54P/E (TTM)

About Biogen Company

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Company Profile

SymbolBIIB
Company NameBiogen
Listing DateSep 17, 1991
Issue Price15.00
Founded1978
CEOMr. Christopher A. Viehbacher
MarketNASDAQ
Employees7570
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address225 Binney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-679-2000

Company Executives

  • Name
  • Position
  • Salary
  • Christopher A. Viehbacher
  • Director, President and Chief Executive Officer
  • 4.07M
  • Michael R. Mcdonnell
  • Executive Vice President and Chief Financial Officer
  • 7.17M
  • Dr. Ginger Gregory, PhD
  • Executive Vice President and Chief Human Resources Officer
  • --
  • Susan H. Alexander
  • Executive Vice President and Chief Legal Officer
  • 6.70M
  • Robin C. Kramer
  • Senior Vice President and Chief Accounting Officer
  • --
  • Rachid Izzar
  • Executive Vice President, Global Product Strategy and Commercialization
  • 5.45M
  • Nicole Murphy
  • Executive Vice President, Pharmaceutical Operations and Technology
  • 5.71M
  • Dr. Priya Singhal, M.D.,M.P.H.
  • Executive Vice President and Head of Development
  • --
  • Dr. Jane Grogan, PhD
  • Executive Vice President, Head of Research
  • --
  • Adam Keeney, PhD
  • Executive Vice President, Head of Corporate Development
  • --
  • Caroline D. Dorsa
  • Chairman of the Board
  • 646.13K
  • Dr. Stephen A. Sherwin, M.D.
  • Independent Director
  • 435.32K
  • Jesus B. Mantas
  • Independent Director
  • 433.23K
  • Dr. Eric K. Rowinsky,M.D.
  • Independent Director
  • 418.02K
  • William A. Hawkins, III
  • Independent Director
  • 425.73K
  • Dr. Maria C. Freire, PhD
  • Independent Director
  • 412.90K
  • Susan Langer
  • Independent Director
  • 334.53K
  • Monish D. Patolawala
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg